150 related articles for article (PubMed ID: 36646243)
1. Ten-Year Follow-up Results of Pure Ground-Glass Opacity-Featured Lung Adenocarcinomas After Surgery.
Li D; Deng C; Wang S; Li Y; Zhang Y; Chen H
Ann Thorac Surg; 2023 Aug; 116(2):230-237. PubMed ID: 36646243
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
[TBL] [Abstract][Full Text] [Related]
3. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller.
Zhang C; He Z; Cheng J; Cao J; Hu J
Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898
[TBL] [Abstract][Full Text] [Related]
4. Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy.
Zhang Y; Deng C; Ma X; Gao Z; Wang S; Zheng Q; Xia G; Wen Z; Han H; Fu F; Liu Q; Hu H; Li Y; Wong KK; Chen H
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2411-2417. PubMed ID: 32356178
[TBL] [Abstract][Full Text] [Related]
5. Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative.
Li D; Deng C; Wang S; Li Y; Zhang Y; Chen H
J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1614-1622.e1. PubMed ID: 35965138
[TBL] [Abstract][Full Text] [Related]
6. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
[TBL] [Abstract][Full Text] [Related]
7. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
8. Ground glass opacity featured lung adenocarcinoma in teenagers.
Wu H; Zhang Y; Hu H; Li Y; Shen X; Liu Q; Wang S; Chen H
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3719-3724. PubMed ID: 33829316
[TBL] [Abstract][Full Text] [Related]
9. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
[TBL] [Abstract][Full Text] [Related]
10. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
[TBL] [Abstract][Full Text] [Related]
11. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
Zhang Y; Fu F; Chen H
Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection.
Moon Y; Lee KY; Park JK
J Thorac Dis; 2017 Oct; 9(10):3782-3792. PubMed ID: 29268386
[TBL] [Abstract][Full Text] [Related]
13. Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival.
Berry MF; Gao R; Kunder CA; Backhus L; Khuong A; Kadoch M; Leung A; Shrager J
Clin Lung Cancer; 2018 Jan; 19(1):e47-e51. PubMed ID: 28743420
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
[TBL] [Abstract][Full Text] [Related]
15. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
[TBL] [Abstract][Full Text] [Related]
16. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
[TBL] [Abstract][Full Text] [Related]
17. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
18. Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.
Phillips WW; Gill RR; Mazzola E; Armitage JR; de Forcrand C; Colson YL; Gibney BC
Ann Thorac Surg; 2021 Oct; 112(4):1067-1075. PubMed ID: 33181131
[TBL] [Abstract][Full Text] [Related]
19. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity.
Sagawa M; Oizumi H; Suzuki H; Uramoto H; Usuda K; Sakurada A; Chida M; Shiono S; Abe J; Hasumi T; Sato M; Sato N; Shibuya J; Deguchi H; Okada Y
Eur J Cardiothorac Surg; 2018 Apr; 53(4):849-856. PubMed ID: 29236995
[TBL] [Abstract][Full Text] [Related]
20. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
